Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of EMLA cream and lidocaine spray with rhythmic breathing for needle insertion pain in hemodialysis patients
IRCT20220512054826N1Phase 2Completed
- Sponsor
- Gonabad University of Medical Sciences
- Start
- Jun 2022
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of lidocaine + prilocaine and lidocaine in end-stage kidney disease (ESKD) (2 arms), sponsored by Gonabad University of Medical Sciences. Primary endpoint: pain_intensity_needle_insertion. Started Jun 2022; status: completed.
02
Drugs
lidocaine + prilocainelidocaine
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on IRCT20220512054826N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220512054826N1.